JP2009511892A5 - - Google Patents

Download PDF

Info

Publication number
JP2009511892A5
JP2009511892A5 JP2008535094A JP2008535094A JP2009511892A5 JP 2009511892 A5 JP2009511892 A5 JP 2009511892A5 JP 2008535094 A JP2008535094 A JP 2008535094A JP 2008535094 A JP2008535094 A JP 2008535094A JP 2009511892 A5 JP2009511892 A5 JP 2009511892A5
Authority
JP
Japan
Prior art keywords
variable domain
chain variable
antibody
heavy chain
light chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008535094A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009511892A (ja
Filing date
Publication date
Priority claimed from GB0520644A external-priority patent/GB0520644D0/en
Priority claimed from GB0521140A external-priority patent/GB0521140D0/en
Application filed filed Critical
Priority claimed from PCT/GB2006/003781 external-priority patent/WO2007042809A2/en
Publication of JP2009511892A publication Critical patent/JP2009511892A/ja
Publication of JP2009511892A5 publication Critical patent/JP2009511892A5/ja
Pending legal-status Critical Current

Links

JP2008535094A 2005-10-11 2006-10-11 抗体ポリペプチドライブラリーのスクリーニングと選択された抗体ポリペプチド Pending JP2009511892A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0520644A GB0520644D0 (en) 2005-10-11 2005-10-11 Antibody polypeptide library screening and selected antibody polypeptides
GB0521140A GB0521140D0 (en) 2005-10-18 2005-10-18 Antibody polypeptide library screening and selected antibody polypeptides
PCT/GB2006/003781 WO2007042809A2 (en) 2005-10-11 2006-10-11 Antibody polypeptide library screening and selected antibody polypeptides

Publications (2)

Publication Number Publication Date
JP2009511892A JP2009511892A (ja) 2009-03-19
JP2009511892A5 true JP2009511892A5 (https=) 2009-10-22

Family

ID=37943170

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008535094A Pending JP2009511892A (ja) 2005-10-11 2006-10-11 抗体ポリペプチドライブラリーのスクリーニングと選択された抗体ポリペプチド

Country Status (6)

Country Link
US (1) US20100168393A1 (https=)
EP (1) EP1951754A2 (https=)
JP (1) JP2009511892A (https=)
AU (1) AU2006300951A1 (https=)
CA (1) CA2625222A1 (https=)
WO (1) WO2007042809A2 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2390425T3 (es) 2000-12-22 2012-11-12 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Uso de moléculas de orientación repulsivas (RGM) y sus moduladores
CN101277974A (zh) 2005-09-30 2008-10-01 阿伯特有限及两合公司 排斥性引导分子(rgm)蛋白质家族的蛋白质的结合结构域及其功能性片段和它们的用途
US8962803B2 (en) 2008-02-29 2015-02-24 AbbVie Deutschland GmbH & Co. KG Antibodies against the RGM A protein and uses thereof
CN104004094B (zh) * 2008-06-25 2017-09-22 艾斯巴技术-诺华有限责任公司 使用通用抗体构架进行的兔抗体的人源化
MX345039B (es) 2008-06-25 2017-01-16 Esbatech Alcon Biomed Res Unit Anticuerpos estables y solubles que inhiben el tnfa.
AU2020201002B2 (en) * 2008-06-25 2022-04-07 Novartis Ag Humanization of rabbit antibodies using a universal antibody framework
CN102656190A (zh) 2009-12-08 2012-09-05 雅培股份有限两合公司 用于在视网膜神经纤维层变性治疗中使用的针对rgm a蛋白质的单克隆抗体
US8883985B2 (en) 2010-02-16 2014-11-11 National University Corporation Kyoto Institute Of Technology Antibody-immobilized carrier, method of producing antibody-immobilized carrier, and use of said antibody-immobilized carrier
PL2606064T3 (pl) * 2010-08-16 2015-07-31 Novimmune Sa Sposoby wytwarzania wieloswoistych i wielowartościowych przeciwciał
AR083495A1 (es) 2010-10-22 2013-02-27 Esbatech Alcon Biomed Res Unit Anticuerpos estables y solubles
WO2012105833A1 (en) * 2011-02-01 2012-08-09 Bac Ip B.V. Antigen-binding protein directed against epitope in the ch1 domain of human igg antibodies
NZ714482A (en) 2012-01-27 2017-08-25 Abbvie Inc Composition and method for diagnosis and treatment of diseases associated with neurite degeneration
CN107814845B (zh) * 2016-09-14 2021-02-09 浙江特瑞思药业股份有限公司 新的抗pd-1纳米抗体及其应用
CN107857816B (zh) * 2017-10-17 2020-11-06 北京大学 一种抗干扰素α-2b纳米抗体及其应用
EP3737692A4 (en) 2018-01-09 2021-09-29 Elstar Therapeutics, Inc. CALRETICULIN AND MODIFIED T-LYMPHOCYTES BINDING CONSTRUCTIONS FOR THE TREATMENT OF DISEASES
US12152073B2 (en) 2018-03-14 2024-11-26 Marengo Therapeutics, Inc. Multifunctional molecules that bind to calreticulin and uses thereof
EP3818083A2 (en) 2018-07-03 2021-05-12 Elstar Therapeutics, Inc. Anti-tcr antibody molecules and uses thereof
GB2595980B (en) * 2019-01-04 2023-06-14 Marengo Therapeutics Inc Anti-TCR antibody molecules and uses thereof
JP7710373B2 (ja) 2019-02-21 2025-07-18 マレンゴ・セラピューティクス,インコーポレーテッド T細胞関連のがん細胞に結合する多機能性分子およびその使用
AU2020224681A1 (en) 2019-02-21 2021-09-16 Marengo Therapeutics, Inc. Antibody molecules that bind to NKp30 and uses thereof
CN116234829A (zh) 2020-01-03 2023-06-06 马伦戈治疗公司 抗tcr抗体分子及其用途
EP4341298A4 (en) * 2021-06-22 2025-04-16 University of Virginia Patent Foundation COMPOSITIONS AND METHODS FOR DETECTING AND REGULATING FIBRONECTIN-INTEGRIN INTERACTIONS AND SIGNALING
CN114195891B (zh) * 2021-12-22 2023-05-12 北京世纪沃德生物科技有限公司 一种crp驼源单域抗体及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2136092T3 (es) * 1991-09-23 1999-11-16 Medical Res Council Procedimientos para la produccion de anticuerpos humanizados.
GB9722131D0 (en) * 1997-10-20 1997-12-17 Medical Res Council Method
ZA9811162B (en) * 1997-12-12 2000-06-07 Genentech Inc Treatment with anti-ERBB2 antibodies.
US20060252028A1 (en) * 2002-08-16 2006-11-09 Hiroshi Ueda Method of assaying interaction between proteins
WO2004065611A1 (ja) * 2003-01-21 2004-08-05 Chugai Seiyaku Kabushiki Kaisha 抗体の軽鎖スクリーニング方法
EP1711527A4 (en) * 2003-12-15 2008-09-03 Dendreon Corp HLA-DR SPECIFIC ANTIBODIES, COMPOSITIONS AND METHODS

Similar Documents

Publication Publication Date Title
JP2009511892A5 (https=)
JP7676474B2 (ja) Cd47およびpd-l1に特異的な抗体
US10358493B2 (en) Bispecific format suitable for use in high-through-put screening
US10677787B2 (en) Antibody screening methods
Peng et al. Mining naive rabbit antibody repertoires by phage display for monoclonal antibodies of therapeutic utility
US12247075B2 (en) BTN3A binding proteins and uses thereof
US11332522B2 (en) Modified variable domain molecules and methods for producing them
US20160145328A1 (en) Modified Variable Domain Molecules And Methods For Producing And Using Same
CN107955071A (zh) 人源抗人cd47抗体及其编码基因与应用
JP2009511892A (ja) 抗体ポリペプチドライブラリーのスクリーニングと選択された抗体ポリペプチド
WO2018050027A1 (zh) 一种能够特异性地结合pd-1的抗体及其功能片段
US20080003617A1 (en) Methods for the identification and the isolation of epitope specific antibodies
Sandeep et al. Engineered polyspecific antibodies: A new frontier in the field of immunotherapeutics
JP2009508521A5 (https=)
JP6918399B2 (ja) 抗体ナイーブライブラリーを生成する方法、前記ライブラリー及びその用途
US20170306039A1 (en) Human vh domain scaffolds
JP2012232948A5 (https=)
WO2022037527A1 (zh) 结合bcma的单可变结构域及抗原结合分子
Lai et al. Synthetic Antibody Engineering: Concepts and Applications